AKT2 inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

ERBB3 overexpression	Triple Negative Breast Cancer	ERBB3 overexpression	Triple Negative Breast Cancer	HDAC inhibitor + AKT2 inhibitor Sensitive: C3 – Early Trials HDAC inhibitor + AKT2 inhibitor Sensitive : C3	HDAC inhibitor + AKT2 inhibitor Sensitive: C3 – Early Trials HDAC inhibitor + AKT2 inhibitor Sensitive : C3
NRAS G12D	Prostate Cancer	NRAS G12D	Prostate Cancer	BAY 1125976 Sensitive: D – Preclinical BAY 1125976 Sensitive : D	BAY 1125976 Sensitive: D – Preclinical BAY 1125976 Sensitive : D

Associations(2)